new drug

2 stories · following the connections

Business

CLINUVEL reaches agreement on German SCENESSE® pricing through AMNOG Arbitration Board

By Nasdaq OMXApr 12, 2017, 9:10 AM UTC

Business

Advanced Accelerator Applications Announces New England Journal of Medicine Publication of Lutathera® NETTER-1 Phase III Results

By Nasdaq OMXJan 12, 2017, 1:05 PM UTC